Major pharmaceutical company Eisai Co. has paid 400 million yen in penalties and back taxes for failing to properly declare about 1 billion yen in income during the two years to March 1999, industry sources said Tuesday.

The Tokyo Regional Taxation Bureau slapped the fine on Eisai in connection with accounting mistakes made on conference fees and inventories of clinical drugs.

Unable to view this article?

This could be due to a conflict with your ad-blocking or security software.

Please add japantimes.co.jp and piano.io to your list of allowed sites.

If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.

We humbly apologize for the inconvenience.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.